Business Segment, Geographic and Concentration Risk Information (Tables)

12 Months Ended

Dec. 30, 2016

Segment Reporting [Abstract]

Schedule of segment sales by product line

An analysis and reconciliation of the Company’s business segments, product lines and geographic information to the respective information in the Consolidated Financial Statements follows. Prior period amounts have been reclassified to conform to the new segment reporting presentation. Sales by geographic area for fiscal years 2016, 2015 and 2014 are presented by allocating sales from external customers based on where the products are shipped (in thousands):

	2016			2015			2014
Segment sales by product line:
Medical
Cardio & Vascular	$	568,510		$	143,260		$	58,770
Cardiac & Neuromodulation	389,403			356,064			330,921
Advanced Surgical, Orthopedics & Portable Medical	392,778			243,385			216,339
Elimination of interproduct line sales	(5,592		)	(1,744		)	—
Total Medical	1,345,099			740,965			606,030
Non-Medical	41,679			59,449			81,757
Total sales	$	1,386,778		$	800,414		$	687,787

Schedule of segment income (loss) from operations

	2016			2015			2014
Segment income from operations:
Medical	$	185,448		$	83,784		$	91,677
Non-Medical	1,513			7,289			20,799
Total segment income from operations	186,961			91,073			112,476
Unallocated operating expenses	(78,691		)	(77,927		)	(36,822		)
Operating income	108,270			13,146			75,654
Unallocated expenses, net	(107,085		)	(28,846		)	925
Income (loss) before provision (benefit) for income taxes	$	1,185		$	(15,700	)	$	76,579

Schedule of segment depreciation and amortization

	2016		2015		2014
Segment depreciation and amortization:
Medical	$	83,184	$	61,618	$	31,346
Non-Medical	2,346		2,503		2,661
Total depreciation and amortization included in segment income from operations	85,530		64,121		34,007
Unallocated depreciation and amortization	4,994		3,497		3,450
Total depreciation and amortization	$	90,524	$	67,618	$	37,457

Schedule of expenditures for tangible long-lived assets, excluding acquisitions

	2016		2015		2014
Expenditures for tangible long-lived assets, excluding acquisitions:
Medical	$	44,670	$	40,931	$	19,838
Non-Medical	1,451		600		621
Total reportable segments	46,121		41,531		20,459
Unallocated long-lived tangible assets	8,251		6,523		5,187
Total expenditures	$	54,372	$	48,054	$	25,646

Schedule of sales by geographic area

	2016		2015		2014
Sales by geographic area:
United States	$	805,742	$	401,380	$	312,539
Non-Domestic locations:
Puerto Rico	159,243		136,898		127,702
Belgium	69,149		62,546		65,308
Rest of world	352,644		199,590		182,238
Total sales	$	1,386,778	$	800,414	$	687,787

Schedule of identifable assets and long-lived tangible assets by geographic area

	December 30, 2016		January 1, 2016		January 2, 2015
Identifiable assets:
Medical	$	2,638,180	$	2,766,421	$	763,905
Non-Medical	60,988		66,492		73,849
Total reportable segments	2,699,168		2,832,913		837,754
Unallocated assets	133,375		149,223		117,368
Total assets	$	2,832,543	$	2,982,136	$	955,122

	December 30, 2016		January 1, 2016		January 2, 2015
Long-lived tangible assets by geographic area:
United States	$	258,899	$	264,556	$	113,851
Rest of world	113,143		114,936		31,074
Total	$	372,042	$	379,492	$	144,925

Schedule of Revenue by Major Customers by Reporting Segments

A significant portion of the Company’s sales for fiscal years 2016, 2015 and 2014 and accounts receivable at December 30, 2016 and January 1, 2016 were to four customers as follows:

	Sales						Accounts Receivable
	2016		2015		2014		December 30, 2016		January 1, 2016
Customer A	18	%	17	%	18	%	7	%	8	%
Customer B	17	%	18	%	18	%	20	%	23	%
Customer C	12	%	12	%	12	%	4	%	6	%
Customer D	9	%	5	%	5	%	14	%	7	%
	56	%	52	%	53	%	45	%	44	%